| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenues | 4.632 | 3.219 | - | - |
| Cost of revenue | 0.781 | 2.156 | - | - |
| Gross profit | 3.851 | 1.063 | - | - |
| Impairment of inventory | - | - | - | 60 |
| General and administrative | 250.971 | 197.892 | 143.383 | 40.396 |
| Professional fees | 17.069 | 81.39 | 105.765 | 21.545 |
| Amortization and impairment loss of license and patent | 1.5 | 1 | - | - |
| Impairment of inventory | 0 | 0 | - | - |
| Total operating expenses | 269.54 | 280.282 | 249.148 | 121.941 |
| Loss from operations | -265.689 | -279.219 | -249.148 | -121.941 |
| Interest expense | 14.153 | 9.649 | 9.647 | 9.697 |
| Change in fair value of derivative liabilities | -201.36 | 130.954 | 61.659 | 93.989 |
| Gain on settlement of debt | 101.7 | - | - | - |
| Other income | 0 | 0 | - | - |
| Total other income (expense) | -113.813 | 121.305 | 52.012 | 84.292 |
| Loss before income taxes | -379.502 | -157.914 | -197.136 | -37.649 |
| Net loss | -379.502 | -157.914 | -197.136 | -37.649 |
| Basic eps | - | - | - | 0 |
| Basic average shares | - | - | - | 895,760,225 |
| Basic and diluted | -0.04 | 0.02 | -0.02 | - |
| Basic and diluted | 10,239,290 | 9,533,375 | 9,048,725 | - |
BIOADAPTIVES, INC. (BDPT)
BIOADAPTIVES, INC. (BDPT)